Marc Tessier-Lavigne

Companies

• Denali Therapeutics Inc.Board member Dec 7, 2017 to now¹
• Regeneron PharmaceuticalsBoard member Nov 22, 2011 to Jan 5, 2023²
• Agios PharmaceuticalsBoard member Jul 23, 2013 to Jun 23, 2016³
• PfizerBoard member Dec 13, 2011 to Apr 24, 2015⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• DTDenali Therapeutics Inc. DNLI1,965,424 shares⁵$35.9M at $18.25Jun 5, 2025
• Regeneron Pharmaceuticals REGN2,434 shares⁶$1.9M at $790.61Jan 3, 2023
• Pfizer PFE104 shares⁷$3.1K at $29.54Dec 29, 2011

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 3, 2025Granted 6,037 shares of Denali Therapeutics Inc.⁵
• May 31, 2024Granted 5,967 shares of Denali Therapeutics Inc.⁸
• Jun 1, 2023Granted 4,216 shares of Denali Therapeutics Inc.⁹
• Jan 3, 2023Granted 165 shares of Regeneron Pharmaceuticals⁶
• Jan 3, 2023Granted 165 shares of Regeneron Pharmaceuticals¹⁰
• Nov 23, 2022Sold 20,000 shares at $30.48 of Denali Therapeutics Inc.¹¹
• Nov 2, 2022Sold 11,252 shares at $30.33 of Denali Therapeutics Inc.¹²
• Nov 1, 2022Sold 8,748 shares at $30.20 of Denali Therapeutics Inc.¹²
• Oct 3, 2022Sold 3,612 shares at $718.00 of Regeneron Pharmaceuticals¹³
• Oct 3, 2022Exercised options 3,612 shares at $413.33 of Regeneron Pharmaceuticals¹³
• Sep 30, 2022Sold 3,428 shares at $698.00 of Regeneron Pharmaceuticals¹³
• Sep 30, 2022Exercised options 3,428 shares at $413.33 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Sold 20 shares at $704.83 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Sold 16 shares at $702.36 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Sold 80 shares at $699.82 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Sold 208 shares at $698.44 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Sold 160 shares at $697.29 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Sold 85 shares at $696.13 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Sold 554 shares at $691.59 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Sold 692 shares at $690.65 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Sold 1,009 shares at $689.56 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Sold 637 shares at $688.71 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Sold 321 shares at $687.90 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Sold 16 shares at $686.89 of Regeneron Pharmaceuticals¹³
• Sep 29, 2022Exercised options 3,798 shares at $413.33 of Regeneron Pharmaceuticals¹³